En Es
Categorías

Hologic

Designs and provides products for clinical laboratory and blood screening, including testing items for detection of human diseases, such as tuberculosis, strep throat, pneumonia, and sexually transmitted diseases, as well as for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) contamination of bloo ...
Productos Covid-19NoticiasResumen
Close

Covid-19 Hologic

Laboratorio clínico

COVID-19 Assay
Novodiag COVID-19 Assay

The Novodiag COVID-19 assay, performed with the Novodiag System, is a cartridge-based RT-PCR test for qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The CE marked test uses nasopharyngeal swab samples from patients and delivers clinical confidence in approximately an hour.
Mas detalles

PRUEBA DE SARS-COV-2
SARS-CoV-2 Trifecta

La prueba SARS-CoV-2 Trifecta para pruebas de SARS-CoV-2 tiene una sensibilidad superior y simplifica el flujo de trabajo, ya que se puede recolectar y cargar directamente en el sistema Panther sin destapar ni transferir muestras.
Mas detalles

Direct Load Tube Collection Kit
Direct Load Tube Collection Kit

The Direct Load Tube Collection Kit transforms specimen processing for COVID testing by eliminating the need for uncapping and specimen transfer. Labs can expedite their SARS-CoV-2 workflow with the collection device that loads directly on the Panther system.
Mas detalles

Direct Load Capture Cap Collection Kit
Direct Load Capture Cap Collection Kit

The Direct Load Capture Cap Collection Kit transforms specimen processing for COVID testing by eliminating the need for uncapping and specimen transfer. Labs can expedite their SARS-CoV-2 workflow with the collection device that loads directly on the Panther system.
Mas detalles

SARS-CoV-2 Assay
Panther Fusion SARS-CoV-2 assay

The Panther Fusion SARS-CoV-2 assay is a real-time PCR in vitro diagnostic test utilizing Hologic's proprietary TMA technology for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from nasopharyngeal, nasal and oropharyngeal swab specimens and lower respiratory tract specimens obtained from individuals who meet COVID-19 clinical and/or epidemiological criteria. The assay runs on both Hologic's Panther® and Panther Fusion systems®, enabling labs to run over 10,00 tests in 24 hours and attain first results in 3.5 hours or less.
Mas detalles

SARS-CoV-2 Assay
Aptima SARS-CoV-2 assay

The Aptima SARS-CoV-2 assay is an in vitro diagnostic test utilizing Hologic's proprietary TMA technology for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from nasopharyngeal, nasal and oropharyngeal swab specimens obtained from individuals who meet COVID-19 clinical and/or epidemiological criteria. The assay runs on both Hologic's Panther® and Panther Fusion systems®, enabling labs to run over 10,00 tests in 24 hours and attain first results in 3.5 hours or less.
Mas detalles
Close

Noticias of Hologic

Hologic Acquires Bolder Surgical to Expand Surgical Franchise

20 Oct 2021
Hologic Acquires Bolder Surgical to Expand Surgical Franchise
Hologic, Inc. (Marlborough, MA, USA) is set to acquire Bolder Surgical (Louisville, CO, USA; www.boldersurgical.com), a provider of advanced energy vessel sealing surgical devices, in a deal that will expand its surgical franchise.
Más info

Hologic Completes Acquisition of Mobidiag

24 Jun 2021
Hologic Completes Acquisition of Mobidiag
Hologic, Inc. (Marlborough, MA, USA) has completed its previously announced acquisition of Mobidiag Ltd. (Espoo, Finland), an innovator in near-patient, acute care molecular diagnostic testing, for an enterprise value of approximately USD 808 million.
Más info

Hologic Acquires European Molecular Diagnostic Company Diagenode

02 Mar 2021
Hologic Acquires European Molecular Diagnostic Company Diagenode
Hologic, Inc. (Marlborough, MA, USA) has acquired Diagenode (Liège, Belgium), a developer and manufacturer of molecular diagnostic assays and epigenetics products, which is expected to diversify its diagnostic business across test menu, customer segments and geography.
Más info

Hologic Partners with Google Cloud to Focus on AI and Machine Learning for Advancing Digital Diagnostic Capabilities

04 Feb 2021
Hologic Partners with Google Cloud to Focus on AI and Machine Learning for Advancing Digital Diagnostic Capabilities
Hologic, Inc. (Marlborough, MA, USA) and Google Cloud have entered into a new agreement to focus on enhancing artificial intelligence (AI) and machine learning (ML) to bring about breakthrough results in cervical cancer screening.
Más info

Hologic to Acquire Diagnostic Tests Provider Biotheranostics

07 Jan 2021
Hologic to Acquire Diagnostic Tests Provider Biotheranostics
Hologic, Inc. (Marlborough, MA, USA) has agreed to acquire Biotheranostics, Inc. (San Diego, CA, USA), a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately USD 230 million.
Más info

Hologic Acquires SOMATEX Medical Technologies

05 Jan 2021
Hologic Acquires SOMATEX Medical Technologies
Hologic, Inc. (Marlborough, MA, USA) has completed the acquisition of SOMATEX Medical Technologies GmbH (Berlin, Germany), a leader in biopsy site markers and localization technologies, for approximately USD 64 million.
Más info

Hologic Receives FDA Clearance for Genius AI Detection Technology for Early Breast Cancer Detection

02 Dec 2020
Hologic Receives FDA Clearance for Genius AI Detection Technology for Early Breast Cancer Detection
Hologic, Inc. (Marlborough, MA, USA) has received US Food and Drug Administration (FDA) clearance for its Genius AI Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images.
Más info

Hologic Showcased Latest Advances at Virtual ECR Congress 2020

20 Aug 2020
Hologic Showcased Latest Advances at Virtual ECR Congress 2020
Hologic, Inc. (Marlborough, MA, USA) showcased its latest advances and shared its new innovations on its virtual booth at the online ECR 2020 event held on July 15-21.
Más info

Hologic to Sell Blood-Screening Business to Grifols for USD 1.85 Billion

15 Dec 2016
Hologic to Sell Blood-Screening Business to Grifols for USD 1.85 Billion
US medical device maker Hologic, Inc. has agreed to sell off its share of the Procleix blood-screening business to long-time partner, Grifols SA, for USD 1.85 billion in cash.
Más info
Close

Sobre Hologic

Número de empleados: 1000+
Año de establecimiento 1986
Designs and provides products for clinical laboratory and blood screening, including testing items for detection of human diseases, such as tuberculosis, strep throat, pneumonia, and sexually transmitted diseases, as well as for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) contamination of blood supply
Facebook Twitter Google+ Linked in
Endometrial Ablation (GEA) Device

Endometrial Ablation (GEA) Device

Modelo: NovaSure V5
Solicite información

Descripción:

The new NovaSure V5 global endometrial ablation (GEA) device has an updated cervical seal, featuring EndoForm technology, designed to increase the sealing surface and accommodate a range of cervical canals and anatomical variability. The device’s AccuSheath markings are designed to improve the accuracy and confidence of seating and fundal placement.
Más info

Descripción completa Características:

Descripción

The new NovaSure V5 global endometrial ablation (GEA) device has an updated cervical seal, featuring EndoForm technology, designed to increase the sealing surface and accommodate a range of cervical canals and anatomical variability. The device’s AccuSheath markings are designed to improve the accuracy and confidence of seating and fundal placement. It is also equipped with SureClear technology, Hologic's unique fluid removal system, which provides integrated suction through the array by constant tissue contact while simultaneously removing ablation by products such as vapor and fluid from the uterus. The NovaSure V5 endometrial ablation system is not only outfitted to support the physician through comfort and control but is also specifically designed to cater to various cervical canal sizes. Solicite información

Características:

• Features simple device replacement guarantee
• Addition of sheath markings designed to increase accuracy and confidence of device seating and placement
• SureClear™ technology provides constant contact with the array while suctioning vapor, blood and desiccated endometrium
• SmartDepth™ technology monitors and measures tissue impedance for a customized depth of ablation for each patient
• Features unique Moisture Transport® system powered by integrated suction, providing constant tissue contact with the array, even in irregular anatomy
• Requires 14% less dilation than a competitive GEA device and features rounded tips in innovative 6-mm sheath for ease of insertion Solicite información

Enviar un mensaje al proveedor

* Información requerida
* Email:
Para
Hologic ()
* Mensaje

Derecho de autor © 2000-2021 TradeMed.com. Todos los derechos reservados. | Términos y condiciones